BioSpace News Archive

Medical technology company, Pneuma Systems Corporation, has entered into a product development collaboration with Takeda with the goal of improving the patient experience.

Moderna, Inc. today announced Health Canada has approved the New Drug Submission (NDS-CV) for SPIKEVAX™ (elasomeran mRNA vaccine), which has been known as COVID-19 Vaccine Moderna, for active immunization to prevent COVID-19 in individuals 12 years of age and older.

Virpax ® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug application to begin a Phase I trial of BMF-219,

Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS).

Elite HRT, a leading force in hormone replacement therapy wellness, has just published guidance on how to approach this treatment.

Bantam Pharmaceutical today announced that it has completed a $25 million Seed Funding to finalize its ongoing IND-enabling activities for its lead program, BTM-3566, and consummate preparations for first in human clinical trials.

Imvax , Inc. announced the appointment of John M. Limongelli as the Company’s Chief Legal Officer effective September 16, 2021.

Leading biotech beauty brand, Codex Beauty Labs , has been granted two U.S. patents related to its newest skincare line, Antü®.

Pfizer Canada ULC and BioNTech SE today announced that Health Canada has granted full approval (Notice of Compliance or NOC) for COMIRNATY® to prevent COVID-19 in individuals 12 years of age and older.